Condition: Pancreatic Cancer · Sponsor: University of Illinois at Chicago
This study elucidates the effects of the intravenous (IV) lidocaine infusion on the biology of pancreatic circulating tumor cells (CTCs) isolated from patients undergoing robotic pancreatectomy for all types of pancreatic cancer. A prospective randomized controlled double blinded trial design will be used for the proposed study.
This description comes directly from the study's public registry record.
Alexandra Barabanova, MS · (312)996-4020 · barabano@uic.edu
Gina E. Votta-Velis, MD PhD · (312)996-4020 · barabano@uic.edu
Always discuss trial participation with your own doctor first.
| University of Illnois at Chicago | Chicago, Illinois, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04048278